Article info
Cervical Cancer
MiR-34a Inhibits Viability and Invasion of Human Papillomavirus–Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin
- Address correspondence and reprint requests to Fangling Ning, PhD, Department of Oncology, Binzhou Medical University Hospital, No. 661, Huanghe 2nd Rd, Binzhou, Shandong 256603, China. E-mail: Fanglingning{at}163.com.
Citation
MiR-34a Inhibits Viability and Invasion of Human Papillomavirus–Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin
Publication history
- Received November 3, 2014
- Accepted December 24, 2014
- First published May 1, 2015.
Online issue publication
February 27, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2015 by IGCS and ESGO